Christine Teipen Smith
Eli Lilly And Company
Executive Director - Global Quality Systems
Christine Teipen Smith is an Executive Director for Global Quality Systems at Eli Lilly and Company, in Indianapolis, Indiana. She and her team support quality and laboratory systems for Lilly global manufacturing and enterprise. Her work focuses on topics such as quality culture, as well as quality management systems, including data integrity and deviation management. Christine is a member of the ISPE Advancing Pharmaceutical Quality Core Team and an author on the APQ Guide for Cultural Excellence.
Christine has over 23 years of pharmaceutical manufacturing experience at Lilly, much of it spent in support of parenteral manufacturing, where she held positions of increasing responsibility in the quality control, operations, and quality assurance functions. She has further experience in the external manufacturing and consumer product complaint organizations. Christine holds a bachelor’s degree in biology from Purdue University in West Lafayette, Indiana.
Christine has over 23 years of pharmaceutical manufacturing experience at Lilly, much of it spent in support of parenteral manufacturing, where she held positions of increasing responsibility in the quality control, operations, and quality assurance functions. She has further experience in the external manufacturing and consumer product complaint organizations. Christine holds a bachelor’s degree in biology from Purdue University in West Lafayette, Indiana.